BeBetter Med Cash Flow Statement

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2024	FY 2021	FY 2020	FY 2019
Period Ending	Dec '24 Dec 31, 2024	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019
Net Income	-56	-136.9	-61.26	-58.94
Depreciation & Amortization	11.32	2.4	1.03	0.94
Other Amortization	2.13	-	-	-
Asset Writedown & Restructuring Costs	-0.11	-	-	-
Loss (Gain) From Sale of Investments	-3.43	-0.31	-3	0.02
Provision & Write-off of Bad Debts	-	0.03	0.06	0.05
Other Operating Activities	0.43	6.45	1.5	-
Change in Accounts Receivable	8.41	-8.86	-1.84	0.64
Change in Inventory	-	0.15	-0.09	-0.06
Change in Accounts Payable	-80.54	1.47	21.7	21.75
Change in Other Net Operating Assets	28.08	34.69	-	30.51
Operating Cash Flow	-89.61	-100.88	-41.9	-5.07
Capital Expenditures	-18.93	-5.88	-0.67	-0.79
Sale of Property, Plant & Equipment	0	-	-	-
Investment in Securities	-102.51	-	3	-
Other Investing Activities	1.96	0.31	-	-
Investing Cash Flow	-119.47	-5.57	2.33	-0.79
Long-Term Debt Repaid	-	-1.23	-8.7	-
Net Debt Issued (Repaid)	-	-1.23	-8.7	-
Issuance of Common Stock	-	562.35	212.5	30
Other Financing Activities	-5.79	-6.08	-1.5	-
Financing Cash Flow	-5.79	555.05	202.3	30
Foreign Exchange Rate Adjustments	0.02	-	-	-
Net Cash Flow	-214.85	448.6	162.72	24.14
Free Cash Flow	-108.54	-106.76	-42.58	-5.86
Free Cash Flow Margin	-	-11002.82%	-11295.58%	-1671.95%
Free Cash Flow Per Share	-0.31	-0.30	-	-
Cash Income Tax Paid	0.06	0.1	0.04	0.02
Levered Free Cash Flow	-	-64.79	-26.23	-
Unlevered Free Cash Flow	-	-64.71	-26.23	-
Change in Working Capital	-43.96	27.46	19.77	52.85

Source: S&P Global Market Intelligence. Standard template. Financial Sources.